In response to the DEA publishing its extension of tele-prescription rules, CHI released the following statement.
“The Connected Health Initiative commends the Administration’s extension of telemedicine flexibilities for prescribing controlled medications, ensuring continued access for countless patients who rely on digital healthcare options.”
“This temporary measure does not address the critical need for a permanent policy that allows providers and patients to streamline treatment while maintaining safety and security. CHI remains committed to working with the DEA, the incoming Administration, Congress, and other stakeholders to create a sustainable and responsible tele-prescribing framework.”
